Nerolidol

Product Details

CAS No:40716-66-3

MF:C15H26O

Appearance:colorless or light-yellow transparent liquid

Specification:98.5%

Package:1/5/10/25kgs/drum

Supply Capacity:Tons

Synonyms:Nerolidol; (6E)-3,7,11-Trimethyldodeca-1,6,10-trien-3-ol; 3-Hydroxy-3,7,11-trimethyl-1,6,10-dodecatriene; Teprenone Impurity 19;trans-Nerolidal solution;(6E)-3,7,11-Trimethyl-1,6,10-dodecatrien-3-ol;1,6,10-Dodecatrien-3-ol, 3,7,11-trimethyl-, (E)-;Trans-(E)-Nerolidol;3-Hydroxy-3,7,11-trimethyl-1,6,10-dodecatriene;(E)-3,7,11-trimethyldodeca-1,6,10-trien-3-ol;nerolidol,(6E)-3,7,11-trimethyl-1,6,10-dodecatrien-3-ol,peruviol,trans-nerolidol; Nerolidol,"NEROLIDOL; 7212-44-4; (6E)-3,7,11-trimethyldodeca-1,6,10-trien-3-ol; Stirrup; 3,7,11-Trimethyl-1,6,10-dodecatrien-3-ol; FEMA No. 2772; 3-Hydroxy-3,7,11-trimethyl-1,6,10-dodecatriene; CHEBI:7524; DTXCID602247; QR6IP857S6; DTXSID3022247; (Z)-Nerolidol; nerodilol; FCI-119B; 205-540-2; 230-597-5; 89V5Z0JC8J; trans-Nerolidol; 40716-66-3; 3,7,11-Trimethyldodeca-1,6,10-trien-3-ol; Nerolidol trans-form; FCI 119b; (+)-Nerolidol; 1,6,10-Dodecatrien-3-ol, 3,7,11-trimethyl-, (6E)-; (E)-3,7,11-Trimethyldodeca-1,6,10-trien-3-ol; (6E)-nerolidol; (E)-nerolidol; Nerolidol (natural); FG5V0N8P2H; DTXSID2040783; MFCD00008911; (3s)-3,7,11-trimethyldodeca-1,6,10-trien-3-ol; 1,6,10-Dodecatrien-3-ol, 3,7,11-trimethyl-; NCGC00095837-01; (.+/-.)-Nerolidol; Trans-Nerolidol (>90%); trans nerolidol; 1,6,10-Dodecatrien-3-ol, 3,7,11-trimethyl-, (E)-; Nerolidol (E); Methylvinylhomogeranyl carbinol; 3,7,11-Trimethyl-1,6,10-dodecatriene-3-ol; EINECS 230-597-5; UNII-FG5V0N8P2H; EPA Pesticide Chemical Code 128910; BRN 1724135; UNII-QR6IP857S6; AI3-10519; CCRIS 7678; E-Nerolidol; .beta.-Nerolidol; .alpha.-Nerolidol; EINECS 255-053-4; Nerolidol (Standard); Nerolidol (cis/trans); Spectrum5_000460; .+/-.-trans-Nerolidol; NEROLIDOL, TRANS-; Nerolidol (cis and trans); EC 230-597-5; trans-Nerolidol (Standard); (6E)-(+/-)-nerolidol; BSPBio_002958; 3-01-00-02042 (Beilstein Handbook Reference); CHEMBL25424; SCHEMBL114136; SPECTRUM1502251; orb1693703; DTXCID0020783; FEMA 2772; HY-N1944R; HY-N6635R; CHEBI:141283; NEROLIDOL TRANS-FORM [MI]; HMS5084M10; HY-N1944; HY-N6635; Tox21_111527; Tox21_301382; trans-Nerolidol, analytical standard; BBL018508; CCG-38883; MSK168607; s5345; SBB007741; STL193540; AKOS015902890; AKOS025310880; FN33788; FN33789; SDCCGMLS-0066709.P001; NEROLIDOL, (6E)-(+/-)-; NCGC00095837-02; NCGC00095837-03; NCGC00255198-01; 1ST40226; 35944-21-9; AS-16074; AS-75500; DA-56113; ST059434; CAS-7212-44-4; 1ST168607; CAS-40716-66-3; CS-0018255; CS-0044197; N0454; NS00004499; Q415421; SR-05000002467; SR-05000002467-1; (6E)-3,7,11-Trimethyl-1,6,10-dodecatrien-3-ol; trans-3,7,11-trimethyl-dodeca-1,6,10-trien-3-ol; trans-Nerolidol, primary pharmaceutical reference standard; 3-Hydroxy-3,7,11-trimethyl-1,6,10-dodecatriene;3,7,11-Trimethyl-1,6,10-dodecatrien-3-ol; (E)-3,7,11-Trimethyl-1,6,10-dodecatrien-3-ol, trans-3,7,11-Trimethyl-1,6,10-dodecatrien-3-ol",222.370,C15H26O,;